Arovella

Arovella is a company listed under the stock ticker ALA (AU).

View the org chart displaying its 6 main executives

Most searched biographies at Arovella

• Michael Baker, Chief Executive Officer and Director
• Nicole Van Der Weerden, Chief Operating Officer
• Mini Bharathan, Senior Vice President, Development & Translational...

Create your alert
to follow the executive moves at Arovella.

Arovella has 1,907 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals

• Shin Nippon Biomedical Laboratories has announced the acquisition of Satsuma Pharmaceuticals  (posted on April 18 2023).
• Mars has announced the acquisition of Heska  (posted on April 6 2023).
• Navamedic has announced the acquisition of Sensidose  (posted on March 31 2023).

Popular contacts in Pharmaceuticals

• Danilo Cicmil - Supervisory Board Member at Galenika
• Jonathan Leff - Director at Larimar Therapeutics
• Lionel Viret - Chairman of the Board at Groupe Stago

Learn more about the Pharmaceuticals industry >

Press releases by Arovella

• SUDA Pharmaceuticals: Pharmacy And Pharmacology Journal Publishes Impressive ZolpiMistTM Clinical Study Results - Kalkine Media

Social media about Arovella

• Arovella on Wikipedia, Google News & Yahoo Finance
• Arovella on LinkedIn, Twitter & YouTube

Call Arovella at +61 86...

View the org chart

Register to receive your alert

Report an error